Codexis Inc
NASDAQ:CDXS

Watchlist Manager
Codexis Inc Logo
Codexis Inc
NASDAQ:CDXS
Watchlist
Price: 2.46 USD
Market Cap: 203.8m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one CDXS stock under the Base Case scenario is 3.31 USD. Compared to the current market price of 2.46 USD, Codexis Inc is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CDXS Relative Value
Base Case
3.31 USD
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.4
P/S
P/S
Price to Sales
3.4
vs History
60
vs Industry
45
Median 3Y
3.2
Median 5Y
4.6
Industry
3.6
Forward
3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-12.6
Industry
28.6
Forward
-3.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
36
Median 3Y
-4.7
Median 5Y
-34.4
Industry
19.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
24
Median 3Y
-10
Median 5Y
-22.2
Industry
30.9
More Details
3
P/B
P/B
Price to Book Value
3
vs History
63
vs Industry
28
Median 3Y
2.9
Median 5Y
4
Industry
2.3
More Details
2.6
EV/S
EV/S
Enterprise Value to Sales
2.6
vs History
61
vs Industry
48
Median 3Y
2.5
Median 5Y
3.7
Industry
3.3
Forward
2.3
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
58
vs Industry
65
Median 3Y
3.1
Median 5Y
4.7
Industry
7.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-10.7
Industry
16.2
Forward
-3.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-9
Industry
21.1
Forward
-2.9
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
45
Median 3Y
-3.5
Median 5Y
-28.2
Industry
18.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
32
Median 3Y
-3.8
Median 5Y
-17.1
Industry
22.5
More Details
2.2
EV/IC
EV/IC
Enterprise Value to IC
2.2
vs History
74
vs Industry
36
Median 3Y
2.3
Median 5Y
4
Industry
2.1
More Details

Multiples Across Competitors

CDXS Competitors Multiples
Codexis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Codexis Inc
NASDAQ:CDXS
201.4m USD 3.4 -3.1 -2.9 -2.7
US
PerkinElmer Inc
LSE:0KHE
1T USD 372.7 3 601.5 1 262.8 2 575.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
152.2B USD 3.5 23.4 16.4 22.7
US
Danaher Corp
NYSE:DHR
135.8B USD 5.7 36.1 19.9 29
KR
Samsung Biologics Co Ltd
KRX:207940
70.7T KRW 15.6 65.3 36.7 53.3
CH
Lonza Group AG
SIX:LONN
39.3B CHF 6 61.7 22.6 35.3
US
Agilent Technologies Inc
NYSE:A
30.5B USD 4.7 24.2 17.8 20.8
US
IQVIA Holdings Inc
NYSE:IQV
25.9B USD 1.7 19.4 11 16.4
CN
WuXi AppTec Co Ltd
SSE:603259
170.6B CNY 4.2 15.3 14.5 14.5
US
Mettler-Toledo International Inc
NYSE:MTD
22.5B USD 5.9 26.5 19.8 22
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 6.8 94.6 30 53.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Codexis Inc
NASDAQ:CDXS
Average EV/EBITDA: 145.2
Negative Multiple: -2.9 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 262.8
7%
180.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
16.4
8%
2.1
US
Danaher Corp
NYSE:DHR
19.9
7%
2.8
KR
Samsung Biologics Co Ltd
KRX:207940
36.7
17%
2.2
CH
Lonza Group AG
SIX:LONN
22.6
18%
1.3
US
Agilent Technologies Inc
NYSE:A
17.8
10%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
11
9%
1.2
CN
WuXi AppTec Co Ltd
SSE:603259
14.5
23%
0.6
US
Mettler-Toledo International Inc
NYSE:MTD
19.8
6%
3.3
FR
Sartorius Stedim Biotech SA
PAR:DIM
30
19%
1.6

See Also

Summary
CDXS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDXS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDXS stock valuation using valuation multiples.
Wall Street Estimates
CDXS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDXS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 254,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.